{"id":"W2147619880","doi":"10.1158/1078-0432.ccr-10-1382","title":"Tumor Growth Inhibition by Olaparib in <i>BRCA2</i> Germline-Mutated Patient-Derived Ovarian Cancer Tissue Xenografts","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"ca_institutions":"Vancouver General Hospital; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Olaparib; PARP inhibitor; Ovarian cancer; Synthetic lethality; Cancer research; Carboplatin; BRCA mutation; Medicine; Cancer; Serous fluid; Serous carcinoma; In vivo; DNA repair; Biology; Internal medicine; Poly ADP ribose polymerase; Chemotherapy; Cisplatin; DNA; Genetics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002719079,0.000358411,0.0008350736,0.0004326493,0.0002398928,0.00009230911,0.0003148884,0.0004911557,0.004001661],"category_scores_gemma":[0.001051473,0.000333909,0.0001913086,0.0016494,0.001087634,0.0002643751,0.0001811874,0.00401346,0.0002139815],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005428835,"about_ca_system_score_gemma":0.001493434,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005489583,"about_ca_topic_score_gemma":0.002902391,"domain_scores_codex":[0.9939771,0.0007211817,0.001499639,0.001140902,0.001437801,0.001223404],"domain_scores_gemma":[0.9961451,0.0007843453,0.0002668579,0.0007563863,0.001239489,0.0008078812],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.004538729,0.001462351,0.04387299,0.0002172896,0.0001279666,0.0003707637,0.0005119109,0.000005808855,0.7817654,0.0001837962,0.1301102,0.03683276],"study_design_scores_gemma":[0.02167997,0.002557471,0.04374918,0.001155947,0.00007324896,0.00006680326,0.0002068748,0.0002177035,0.7374649,0.001658355,0.190276,0.0008935179],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9786165,0.001393551,0.00003585057,0.01451602,0.001749145,0.001739847,0.0003197138,0.0001512711,0.001478137],"genre_scores_gemma":[0.9891343,0.001973797,0.0003018888,0.004330752,0.001843766,0.001655145,0.0001844684,0.000116226,0.0004597112],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0601658,"threshold_uncertainty_score":0.9999113,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1016430998596772,"score_gpt":0.4953177757048305,"score_spread":0.3936746758451533,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}